The office of Lisa Bero, PhD, on UCSF’s Laurel Heights campus has long been a key portal between the School of Pharmacy and the world at large, including countries where billions of people cannot get even the most vital life-saving drugs.
Now that portal has grown in significance with the September 2011 designation of...
To reduce the risk of toxic drug interactions, UCSF's Kathy Giacomini, PhD, and colleagues are screening thousands of prescription drugs, testing how much they inhibit key proteins in kidney and liver cells that help clear medications from the body.
This is the first large-scale screening of drugs for...
Michael Nordberg, MPA/HSA, is the newly appointed associate dean of administration and finance for the UCSF School of Pharmacy. He served the position as interim associate dean from July 1, 2009 to September 26, 2011 when he accepted the position full time at the completion of a comprehensive recruitment for the job.
In...
Passengers who travel on American Airlines from September through October 2011 will learn about the surgically implantable bioartificial kidney being developed at UCSF as a permanent solution to end stage renal disease.
Directing this national project and speaking on the airline’s in-flight audio program, Shuvo Roy, PhD...
Michael Fischbach, PhD, who studies drug-like molecules produced by human gut bacteria, has been awarded one the 16 prestigious 2011 Packard Fellowships in Science and Engineering.
The fellowship, which supports “highly creative professors early in their careers,” provides an unrestricted research grant of $875,000 over...
Bo Huang, PhD, a faculty member of the UCSF School of Pharmacy, Department of Pharmaceutical Chemistry, has been named a recipient of a 2011 National Institutes of Health (NIH) Director’s New Innovator Award.
The award, given to 49 new investigators this year, including two other UCSF scientists in the School of...
Pharmaceutical companies will increasingly apply the predictive modeling of quantitative pharmacology to do more efficient drug development, says Kathy Giacomini, PhD, co-chair of the Department of Bioengineering and Therapeutic Sciences (BTS), a joint department of the UCSF Schools of Pharmacy and Medicine, and its new Center...
UCSF Chancellor Susan Desmond-Hellman, MD, MPH, delivered her State of the University address at Cole Hall on the Parnassus campus on October 4, 2011.
In her third year at the helm, Desmond-Hellman presented a renewed mission and vision for the university that included five major goals guiding the health sciences...
Adam Abate, PhD, a faculty member in the UCSF Schools of Pharmacy and Medicine, Department of Bioengineering and Therapeutic Sciences, is a prime trial candidate for QB3’s Startup in a Box.
The program by the UCSF-based California Institute for Quantitative Biosciences aims to help researchers convert ideas and...